PHARMACOKINETICS OF NADOLOL, A BETA-RECEPTOR ANTAGONIST - ADMINISTRATION OF THERAPEUTIC SINGLE-DOSAGE AND MULTIPLE-DOSAGE REGIMENS TO HYPERTENSIVE PATIENTS

被引:44
作者
DREYFUSS, J
GRIFFITH, DL
SINGHVI, SM
SHAW, JM
ROSS, JJ
VUKOVICH, RA
WILLARD, DA
机构
[1] SQUIBB INST MED RES,DEPT CLIN PHARMACOL,NEW BRUNSWICK,NJ 08903
[2] SQUIBB INST MED RES,PRINCETON,NJ 08540
[3] MED CTR PRINCETON,PRINCETON,NJ 08540
关键词
D O I
10.1002/j.1552-4604.1979.tb01641.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:712 / 720
页数:9
相关论文
共 10 条
[1]  
COHEN I, 1978, CLIN RES, V26, pA590
[2]   METABOLIC STUDIES IN PATIENTS WITH NADOLOL - ORAL AND INTRAVENOUS ADMINISTRATION [J].
DREYFUSS, J ;
BRANNICK, LJ ;
VUKOVICH, RA ;
SHAW, JM ;
WILLARD, DA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (5-6) :300-307
[3]   ANTI-ARRHYTHMIC ACTION OF NADOLOL, A BETA-ADRENERGIC-RECEPTOR BLOCKING-AGENT [J].
EVANS, DB ;
PESCHKA, MT ;
LEE, RJ ;
LAFFAN, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 35 (01) :17-27
[4]  
FOLEY JE, 1978, CLIN RES, V26, pA591
[5]   CLINICAL PHARMACOKINETICS OF BETA-ADRENORECEPTOR BLOCKERS [J].
JOHNSSON, G ;
REGARDH, CG .
DRUGS, 1976, 11 :111-121
[6]   PHARMACOLOGY OF NADOLOL (SQ 11725), A BETA-ADRENERGIC ANTAGONIST LACKING DIRECT MYOCARDIAL DEPRESSION [J].
LEE, RJ ;
EVANS, DB ;
BAKY, SH ;
LAFFAN, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 33 (02) :371-382
[7]   PRE-CLINICAL TOXICOLOGIC EVALUATION OF NADOLOL, A NEW BETA-ADRENERGIC ANTAGONIST [J].
SIBLEY, PL ;
KEIM, GR ;
KULESZA, JS ;
MURPHY, BF ;
MYHRE, JL ;
PARISH, HM ;
YOON, YH ;
ZAIDI, IH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1978, 44 (02) :379-389
[8]  
SINGHVI SM, 1977, J LAB CLIN MED, V89, P414
[9]   EFFECT OF BETA-BLOCKERS ON EXERCISE DOUBLE PRODUCT (SYSTOLIC BLOOD-PRESSURE X HEART-RATE) [J].
VUKOVICH, RA ;
FOLEY, JE ;
BROWN, B ;
WILLARD, DA ;
BUCKLEY, M ;
OKELLY, D ;
FITZGERALD, D ;
TORMEY, W ;
DARRAGH, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 :S167-S172
[10]  
WAGNER JG, 1975, FUNDAMENTALS CLIN PH